Predicted protein targets (top 7)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | NTSR1 | P30989 | 6/20 | 0.65 |
| ▸ | NTSR2 | O95665 | 5/20 | 0.65 |
| ▸ | SORT1 | Q99523 | 3/20 | 0.65 |
| ▸ | OPRD1 | P41143 | 5/20 | 0.64 |
| ▸ | OPRM1 | P35372 | 1/20 | 0.64 |
| ▸ | OPRK1 | P41145 | 1/20 | 0.64 |
| ▸ | REN | P00797 | 5/20 | 0.61 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14049707 | 0.92 | OPRK1 (0.58) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL10305287 | 0.92 | OPRD1 (0.63) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL1421754 | 0.92 | NTSR1 (0.74) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL1421733 | 0.92 | NTSR1 (0.74) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL10305342 | 0.91 | NTSR1 (0.61) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL14757595 | 0.91 | OPRD1 (0.66) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL10058596 | 0.89 | NTSR1 (0.61) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL30880437 | 0.89 | NTSR1 (0.82) | NTSR1NTSR2SORT1 | |
| SCHEMBL12801534 | 0.88 | NPY1R (0.63) | NTSR1NTSR2SORT1OPRD1OPRM1 | |
| SCHEMBL30775521 | 0.88 | NTSR1 (0.68) | NTSR1NTSR2SORT1OPRD1OPRM1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| CN-114796517-A | Structure modification method for increasing transdermal efficacy of exosome | 安博威生物科技(厦门)有限公司 | 2022-07-29 | — | — | CN | claimed |
| CN-114796517-A | Structure modification method for increasing transdermal efficacy of exosome | 安博威生物科技(厦门)有限公司 | 2022-07-29 | — | — | CN | disclosed |
| EP-2474553-A2 | Compounds for diagnosing apoptosis | GUERBET (FR) | 2012-07-11 | — | — | EP | disclosed |
| WO-2008125420-A2 | COMPOUNDS FOR DIAGNOSING APOPTOSIS | GUERBET (FR) | 2008-10-23 | — | — | WO | disclosed |
| WO-2007042504-A2 | COMPOUNDS COMPRISING A BIOLOGICAL TARGET RECOGNIZING PART, COUPLED TO A SIGNAL PART CAPABLE OF COMPLEXING GALLIUM | GUERBET (FR) | 2007-04-19 | — | — | WO | disclosed |